J Korean Neurol Assoc.  2001 Jul;19(4):407-409.

Verapamil-responsive SUNCT Syndrome

Affiliations
  • 1Department of Neurology, Seoul Municipal Boramae Hospital.
  • 2Department of Neurology, College of Medicine, Seoul National University.

Abstract

SUNCT syndrome is characterized by short-lasting, unilateral, neuralgiform headache attacks, with conjuntival injec-tion and tearing. Distinct from trigeminal neuralgia, cluster headache, or paroxysmal hemicrania, this rare syndrome is SUNCT syndrome is characterized by short-lasting, unilateral, neuralgiform headache attacks, with conjuntival injec-tion and tearing. Distinct from trigeminal neuralgia, cluster headache, or paroxysmal hemicrania, this rare syndrome is generally refractory to various medications. We report a 63-year-old man diagnosed with SUNCT syndrome, whose symptoms were relieved by verapamil. The therapeutic effects of verapamil on SUNCT syndrome remain to be verified by further experiences. (J Korean Neurol Assoc 19(4):407~409, 2001)

Keyword

SUNCT syndrome; Verapamil

MeSH Terms

Cluster Headache
Headache
Humans
Middle Aged
Paroxysmal Hemicrania
SUNCT Syndrome*
Trigeminal Neuralgia
Verapamil
Verapamil
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr